首页> 外文会议>Conference on Laser Florence 2001: A Window on the Laser Medicine World, Nov 7-11, 2001, Florence, Italy >The use of the erbium Yag laser in cataract extraction and other applications in ophthalmic surgery
【24h】

The use of the erbium Yag laser in cataract extraction and other applications in ophthalmic surgery

机译:Yag laser激光在白内障摘除和眼科手术中的其他应用中的用途

获取原文
获取原文并翻译 | 示例

摘要

One of the most important dreams of all ophthalmologists working in anterior segment surgery has always been to perform cataract extraction through an ever smaller incision in the hope which is not so far off to one day have an injectable biocompatible intraocular lens in order to preserve accomodation. With this aim in mind there are many different today techniques exploiting different energy sources at different stages of development. Amongst those laser phacoemulsification has now overtaken an advanced clinical experimentation phase. It is now a new effective technique which flanks the classical ultrasonic phacoemulsification. For the last 7 years we have been working with an Er:YAG laser for cataract extraction. Many technological improvements have been made since the first machine which have led to increasingly efficient and safer prototypes. Opinions have also changed in the sense that five years ago there was a lot of scepticism regarding the possibility of using laser rather than ultrasounds in cataract surgery. Instead today there is an increasing interest on the part of both surgeons and companies, an interest justified by the encouraging results that we are achieving. In 1997 in 37 of these patients we followed with other two sites in Europe an international protocoll of study which allowed the machine to obtain CE approval.
机译:在前节手术中工作的所有眼科医生的最重要的梦想之一一直是通过越来越小的切口进行白内障摘除术,以期到一天之内就拥有一种可注射的生物相容性人工晶状体以保持适应性,这是不希望的。考虑到这一目标,当今有许多不同的技术在不同的开发阶段利用不同的能源。在这些之中,激光超声乳化现已超过了高级的临床实验阶段。现在,这是一种新的有效技术,侧接于经典超声超声乳化术。在过去的7年中,我们一直在使用Er:YAG激光进行白内障摘除。自第一台机器以来,已经进行了许多技术改进,从而使原型变得越来越有效和安全。在五年前,人们对白内障手术中使用激光而不是超声波的可能性抱有很多怀疑态度。取而代之的是,今天,外科医生和公司都对它的兴趣与日俱增,而我们所取得的令人鼓舞的结果也证明了这种兴趣是有道理的。 1997年,我们对其中的37位患者在欧洲的其他两个地点进行了国际研究规程,使该机器获得了CE批准。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号